Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals & Petrochemicals | Small Cap
Health Score : 8.05Jubilant Ingrevia Ltd, operating in the Chemical & Petrochemicals sector, demonstrates a mixed financial performance. The company shows significant strengths in solvency, growth, and profitability, indicating efficient asset management and strong earnings capabilities. Its coverage and financial ratios also reflect good financial health, supported by robust earnings per share and book value. However, the company's liquidity and efficiency ratios suggest potential areas for improvement, particularly in managing short-term assets and turnover. While the company exhibits strong growth and profitability, it needs to focus on improving its liquidity position and operational efficiency to ensure long-term sustainability and competitiveness in the market.
Health Score : 8.05Jubilant Ingrevia Ltd, operating in the Chemical & Petrochemicals sector, demonstrates a mixed financial performance. The company shows significant strengths in solvency, growth, and profitability, indicating efficient asset management and strong earnings capabilities. Its coverage and financial ratios also reflect good financial health, supported by robust earnings per share and book value. However, the company's liquidity and efficiency ratios suggest potential areas for improvement, particularly in managing short-term assets and turnover. While the company exhibits strong growth and profitability, it needs to focus on improving its liquidity position and operational efficiency to ensure long-term sustainability and competitiveness in the market.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
41.22
Industry Median
39.73
Small Cap Median
37.95
P/E RATIO
39.73
P/B RATIO
3.54
Industry Median
2.59
Small Cap Median
2.40
P/S RATIO
2.52
Industry Median
2.52
Small Cap Median
2.34
Others
PEG RATIO
0.00
EV/EBITDA RATIO
18.83
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹693.25 as on Sep 1, 2026.
Growth Score : 10.00The company exhibits strong growth across all key metrics, including revenue, operating profit, earnings per share, assets, and net income. This consistent growth indicates a robust business model and effective management strategies. The company is successfully expanding its operations and increasing its profitability. This should enable the company to attract investors and sustain its competitive advantage.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 623.54 | -3.56 | -13.35 | 1.02 | 5.03 |
| Operating Profit Growth Rate | 618.8 | -34.72 | -22.22 | 21.55 | 9.25 |
| Earnings Per Share (EPS) Growth | 777.71 | -35.48 | -40.55 | 37.37 | 10.65 |
| Asset Growth Rate | 12.36 | 12.35 | 11.06 | 6.27 | 9.35 |
| Net Income Growth Rate | 783.33 | -35.43 | -40.58 | 37.16 | 10.76 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Fine Organic Industries Ltd | 9.40 | 38.63 | Neutral | 480.00 | 112.97 | 417.00 |
| 2 | Alkyl Amines Chemicals Ltd | 8.65 | 50.95 | Highly Overvalued | 257.00 | 35.19 | 201.00 |
| 3 | Atul Ltd | 8.65 | 28.02 | Overvalued | 1031.00 | 202.11 | 689.00 |
| 4 | Epigral Ltd | 8.26 | 16.11 | Undervalued | 566.00 | 77.19 | 332.00 |
| 5 | Galaxy Surfactants Ltd | 8.17 | 29.56 | Undervalued | 475.00 | 42.88 | 267.00 |
| 6 | Clean Science & Technology Ltd | 8.17 | 38.27 | Highly Overvalued | 355.00 | 23.64 | 230.00 |
| 7 | Jubilant Ingrevia Ltd | 8.05 | 39.73 | Neutral | 567.00 | 16.82 | 278.00 |
| 8 | Privi Speciality Chemicals Ltd | 7.82 | 39.94 | Highly Overvalued | 646.00 | 91.50 | 317.00 |
| 9 | Aether Industries Ltd | 7.47 | 101.80 | Highly Overvalued | 364.00 | 13.08 | 219.00 |
| 10 | Anupam Rasayan India Ltd | 7.42 | 84.32 | Highly Overvalued | 525.00 | 14.18 | 222.00 |
| 11 | Aarti Industries Ltd | 6.89 | 45.40 | Neutral | 1167.00 | 11.63 | 419.00 |
| 12 | Laxmi Organic Industries Ltd | 6.17 | 57.66 | Neutral | 171.00 | 2.86 | 79.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
Jubilant Ingrevia Ltd. is a global integrated life science ingredients and specialty chemicals company. It offers a diverse portfolio including Specialty Intermediates, Nutritional Products, and Chemical Ingredients, serving a wide array of industries such as pharmaceuticals, agrochemicals, nutrition, and consumer goods. The company leverages strong R&D capabilities and backward integration to maintain a competitive market position.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Jubilant Ingrevia Ltd's P/E ratio (TTM) is 41.22, compared to the industry median of 39.73 and large cap median of 37.95.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Jubilant Ingrevia Ltd's P/B ratio is 3.54, compared to the industry median of 2.59 and large cap median of 2.40.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Jubilant Ingrevia Ltd's P/S ratio is 2.52, compared to the industry median of 2.52 and large cap median of 2.34.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Jubilant Ingrevia Ltd's PEG ratio is 2.60.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Jubilant Ingrevia Ltd's EV/EBITDA ratio is 18.83.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Jubilant Ingrevia Ltd's ROE is 8.89%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Jubilant Ingrevia Ltd's ROA is 10.34%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Jubilant Ingrevia Ltd's ROCE is 11%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Jubilant Ingrevia Ltd's operating margin is 12.92%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Jubilant Ingrevia Ltd's net margin is 6.34%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Jubilant Ingrevia Ltd's current ratio is 1.04.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Jubilant Ingrevia Ltd's debt-to-equity ratio is 0.11.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Jubilant Ingrevia Ltd's interest coverage ratio is 8.55.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Jubilant Ingrevia Ltd's DPS is ₹2.44.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Jubilant Ingrevia Ltd's EPS is 10.65.
(Source line: "Ratios as of 06 Oct 2026, based on last traded price of ₹693.25. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1978 (as Vam Organic Chemicals Ltd.)
Headquarters: Noida, Uttar Pradesh
Core Offerings: Specialty Intermediates, Nutritional Products, Chemical Ingredients, Life Science Chemicals, Advanced Intermediates
Stock Listing: NSE (JUBLINGREA), BSE (543271)
Promoter: Jubilant Bhartia Group
['1978: Vam Organic Chemicals Ltd. (predecessor to Jubilant Life Sciences) was founded.', '2001: Renamed to Jubilant Organosys Ltd.', '2008: Renamed to Jubilant Life Sciences Ltd.', '2021: The Life Science Ingredients and Specialty Chemicals business was demerged from Jubilant Life Sciences Ltd. (now Jubilant Pharmova Ltd.) to form a new, separately listed entity, Jubilant Ingrevia Ltd. This strategic move aimed to unlock value and enable focused growth in specialty chemicals and nutritional products.']
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Specialty Intermediates | ~37% | EBITDA share ~50% |
| Nutritional Products | ~33% | EBITDA share ~30% |
| Chemical Ingredients | ~30% | EBITDA share ~20% |
Specialty Intermediates: Manufactures high-value products like Diketene and Pyridine derivatives, serving pharmaceuticals, agrochemicals, polymers, and other specialty applications. This segment is characterized by complex chemistry and strong R&D.
Nutritional Products: A leading global producer of Vitamin B3 (Niacinamide, Niacin) and custom-made nutritional premixes for diverse applications in food, feed, and healthcare industries.
Chemical Ingredients: Produces and markets commodity acetyls such as Acetic Anhydride and Ethyl Acetate, which are critical raw materials for various industrial uses including pharmaceuticals, textiles, and adhesives.
Shyam S Bhartia (Co-Chairman & Managing Director) and Hari S Bhartia (Co-Chairman & Managing Director): Co-founders of the Jubilant Bhartia Group, they possess extensive experience across diverse industries including pharmaceuticals, chemicals, and food services.
Jubilant Life Sciences NV (Belgium): Engaged in marketing and sales of ingredients in Europe.
Jubilant Agro Sciences Limited (India): Focuses on the agri and animal nutrition business.
Hubei Jubilant Aolain Biological Technology Co. Ltd (China): A subsidiary engaged in manufacturing activities.
The most significant corporate action was the demerger of Jubilant Ingrevia Ltd. from Jubilant Life Sciences Ltd. (now Jubilant Pharmova Ltd.) in February 2021, leading to its separate listing.
The Jubilant Ingrevia Ltd share price today is ₹693.25 on NSE (JUBLINGREA), as of 08 Oct 2026.
As of 06 Oct 2026, Jubilant Ingrevia Ltd share price is ₹693.25, with previous close ₹693.25. Today's range is ₹693.25 to ₹693.25. The 52-week range is ₹537.30 to ₹795.
As of today, Jubilant Ingrevia Ltd's market cap is ₹11,043.47 crore (Mid Cap).
Jubilant Ingrevia Ltd's current P/E ratio is 41.22, compared to the CHEMICALS & PETROCHEMICALS sector average of 28.50.
Jubilant Ingrevia Ltd's current P/B ratio is 3.54.
Jubilant Ingrevia Ltd's current dividend yield is 0.35%. Last dividend of ₹2.50 per share was declared on 29-May-2024.
Jubilant Ingrevia Ltd's EPS (TTM) is ₹10.65.
Jubilant Ingrevia Ltd. is a global integrated life science ingredients and specialty chemicals company. It offers a diverse portfolio including Specialty Intermediates, Nutritional Products, and Chemical Ingredients, serving a wide array of industries such as pharmaceuticals, agrochemicals, nutrition, and consumer goods. The company leverages strong R&D capabilities and backward integration to maintain a competitive market position.
Jubilant Ingrevia Ltd is promoted by Jubilant Bhartia Group, holding 45.22% as of 06 Oct 2026.
Jubilant Ingrevia Ltd is listed on NSE (JUBLINGREA) and BSE (543271). Its next quarterly results are expected on August 2024.
Adjusted Earnings Per Share (Adjusted EPS)
Fixed Asset Turnover Ratio